Results 111 to 120 of about 579,519 (167)

Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S-1 for clinical stage III gastric or esophagogastric junction adenocarcinoma. [PDF]

open access: yesAnn Gastroenterol Surg, 2023
Kurokawa Y   +9 more
europepmc   +1 more source

Molecular characteristics of proximal and distal esophagogastric junction adenocarcinoma. [PDF]

open access: yesJ Thorac Dis
Qin X   +7 more
europepmc   +1 more source

Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma. [PDF]

open access: yesDiscov Oncol, 2022
Ding TY   +11 more
europepmc   +1 more source

Screening of molecular biomarkers ASPN and LBH and construction of a prediction nomogram for the progression of esophagogastric junction adenocarcinoma. [PDF]

open access: yesJ Gastrointest Oncol
Chen Y   +12 more
europepmc   +1 more source

Navigating Diagnostic Challenges in Pseudoachalasia: A Case Study of Esophagogastric Junction Adenocarcinoma. [PDF]

open access: yesAm J Case Rep
Nguyen TH   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy